Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Delayed Cyclosporine or Everolimus in Liver Transplant
NCT01023542Phase 3Unknown
- Sponsor
- University of Regensburg
- Start
- Jun 2011
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of everolimus in Liver transplant rejection, sponsored by University of Regensburg. Status: unknown.
02
Drugs
everolimus
03
Conditions
Liver transplant rejection
Beyond the preview
Go deeper on NCT01023542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01023542.